Log in to save to my catalogue

Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression

Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9454580

Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression

About this item

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Background: The pancreatic ductal adenocarcinoma (PDAC) microenvironment is highly fibrotic and hypoxic, with poor immune cell infiltration. Recently, we showed that nucleolin (NCL) inhibition normalizes tumour vessels and impairs PDAC growth. Methods: Immunocompetent mouse models of PDAC were treated by the pseudopeptide N6L, which selectively inh...

Alternative Titles

Full title

Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9454580

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9454580

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers14174265

How to access this item